CCSD Code C3950: Radiotherapy to Conjunctival Lesion Billing Guide

Key Takeaways

CCSD Code C3950 describes radiotherapy to conjunctival lesion, classified as Minor complexity in the CCSD Schedule of Procedures

National Friendly lists C3950 at £197; fees vary by insurer and change periodically, so always verify against each insurer’s current schedule

Individual insurers set their own fees for each CCSD code – CCSD itself does not publish reimbursement amounts

Pabau’s claims management software supports electronic CCSD code submission via Healthcode, reducing manual billing errors for UK ophthalmology practices

Ophthalmology billing in UK private practice demands precision. A misapplied CCSD code – or a claim submitted without the required documentation – can trigger a delay, a query, or an outright rejection from insurers including Bupa, AXA Health, and Freedom Health Insurance. Bupa CCSD codes in particular require close attention to chapter classification and complexity grading. CCSD Code C3950 is one of the codes most likely to generate questions from practitioners who perform radiotherapy to conjunctival lesions but are less familiar with how the CCSD schedule categorises ophthalmic procedures.

This guide covers CCSD Code C3950 in full: its clinical definition, complexity classification, applicable insurer fees, documentation requirements, related conjunctival codes, and how to submit claims electronically through Healthcode. Whether you are an ophthalmologist new to private practice or a billing administrator managing ophthalmic claims, the information below is organised to make code selection and claim submission faster and more accurate.

CCSD Code C3950: Definition and Clinical Description

CCSD Code C3950 is the designated code for radiotherapy to conjunctival lesion within the CCSD Schedule of Procedures, the industry-standard coding framework used by UK private healthcare insurers. The code sits within Chapter 4 of the procedural schedule, which covers the Eye and Orbital Contents – confirmed by Freedom Health Insurance’s published fee schedule for that chapter.

The conjunctiva is the thin, transparent mucous membrane lining the inner surface of the eyelids and covering the anterior sclera. Conjunctival lesions requiring radiotherapy include conditions such as conjunctival lymphoma, squamous cell carcinoma of the conjunctiva, and certain benign lesions where other interventions have been exhausted or are contraindicated. Radiotherapy is typically delivered by a radiation oncologist or specialist ophthalmologist, often in a tertiary or specialist eye centre setting.

CCSD Code C3950 specifically describes the radiotherapy procedure itself. It does not include pre-treatment assessment, planning, or separate diagnostic procedures, which would be coded independently using appropriate diagnostic or consultation codes.

Complexity Classification and Fee Schedule

National Friendly’s published schedule of fees classifies CCSD Code C3950 as Minor complexity, with a listed procedure fee of £197. As Allianz Care UK’s fee schedule makes clear, its schedule – like those of all major UK private insurers – is based on the industry-standard CCSD codes, but each insurer determines its own reimbursement amounts independently. CCSD itself does not publish fee amounts.

The table below summarises published fee data for C3950 and adjacent conjunctival codes from available insurer schedules. Always verify against your specific insurer’s current published schedule before invoicing, as fees are updated periodically.

The Freedom Elite Schedule of Fees, Chapter 4 (Eye and Orbital Contents) (effective 01/01/2026) classifies C3950 as Minor complexity and lists a £200.00 specialist procedure fee with a £213.00 anaesthetist fee. Freedom Health publishes C3950 alongside C3910 and C3920 within the same chapter. Several major insurers including Bupa and AXA Health require practitioners to query fees directly via their portals; the Bupa code search tool allows registered ophthalmologists and billing teams to look up applicable fees by CCSD code before raising an invoice.

C3950 vs Adjacent Conjunctival Codes: Choosing the Right Code

The most common coding error with conjunctival procedures is selecting the wrong treatment modality code. C3950, C3920, and C3910 are all Minor complexity codes covering treatment of conjunctival lesions, but they describe fundamentally different interventions.

• C3910 – Excision/biopsy of conjunctival lesion: Use when the lesion is surgically removed or biopsied for histological analysis. This is the appropriate code for simple conjunctival excision under topical or local anaesthesia.
• C3920 – Cauterisation including cryotherapy: Use when the lesion is treated by thermal cauterisation or cryotherapy. Both techniques are captured under a single code. Freedom Health lists C3920 at £100.00 specialist fee.
• C3950 – Radiotherapy to conjunctival lesion: Use when ionising radiation is applied to the conjunctival lesion as the primary treatment modality. This code is specific to radiotherapy and should not be used for cryotherapy or surgical excision.
• C3960 – Excision of pterygium: A separate code for pterygium-specific excision. Do not use C3950 for pterygium treatment; use C3960 even if adjuvant radiotherapy is delivered to prevent recurrence – in that scenario, coding guidance should be sought from the relevant insurer, as some may allow both codes while others may bundle.

When adjuvant radiotherapy is delivered following surgical excision (for example, post-pterygium excision to reduce recurrence rates), practitioners should contact their insurer directly before coding both C3950 and the relevant surgical code on the same invoice. Some insurers apply unbundling rules. The CCSD Technical Guide (October 2025) provides the authoritative coding principles for situations where multiple procedure codes apply to a single patient episode.

Documentation Requirements for C3950 Claims

Private insurers reviewing C3950 claims expect clinical records that support the decision to use radiotherapy as the treatment modality, rather than cauterisation (C3920) or surgical excision (C3910). Inadequate documentation is the primary reason for coding queries on ophthalmic claims.

Effective private practice management means building documentation into the clinical workflow – not as an afterthought, but as a structured element of every consultation and treatment episode. The checklist below reflects the documentation standard expected by UK private insurers for radiotherapy procedures.

• Clinical indication: A clear note of the diagnosis or suspected diagnosis prompting radiotherapy. For conjunctival lesions, this includes the lesion type, laterality, and any prior treatment attempts.
• Histology or imaging evidence: Where available, include biopsy results, OCT imaging, or slit-lamp findings that support the clinical decision.
• Treatment plan documentation: The radiotherapy plan, including dose, fractionation (if applicable), and the treating specialist’s rationale for choosing radiotherapy over alternative approaches.
• Consent record: Written or electronic consent for the procedure, compliant with UK consent standards and ICO GDPR requirements. Digital clinical forms can capture this at the point of care.
• Pre-authorisation reference: Many insurers require prior authorisation for radiotherapy procedures. Include the insurer’s authorisation reference number on every claim.
• Outcome notes: Post-treatment clinical notes confirming the procedure was performed as planned.

For practices managing multiple insurer relationships, GDPR compliance requires that clinical documentation supporting insurance claims is retained securely, with appropriate access controls, for the duration required under UK data protection law. Practices registered with the CQC should also ensure that clinical records meet the fundamental standards expected during inspection.

How to Bill CCSD Code C3950 Electronically

Most UK private insurers now expect electronic claim submission through recognised platforms. Healthcode is the primary electronic data interchange (EDI) platform used by UK private healthcare providers to submit CCSD-coded claims to insurers including Bupa, AXA Health, Allianz Care, Freedom Health, and The Exeter.

Submitting CCSD Code C3950 through Healthcode follows the same workflow as any other CCSD procedure code. The critical difference for ophthalmology practices is ensuring that the Chapter 4 code set is correctly configured in your billing system. Using claims management software that integrates with Healthcode can significantly reduce the risk of submission errors, missing authorisation references, or incorrect complexity grading being applied at invoice level.

1. Obtain pre-authorisation: Contact the patient’s insurer before performing the procedure. Most insurers require a reference number for radiotherapy procedures. Record this reference in the patient file.
2. Verify membership status: Confirm the patient’s policy is active and covers the procedure. Check whether any excess or co-payment applies.
3. Raise the invoice using the correct CCSD code: Enter C3950 as the procedure code, with the treating consultant’s name, GMC number, and the treatment date. Ensure the Chapter 4 classification is correct.
4. Attach supporting documentation: Some insurers require clinical notes or a treatment summary for radiotherapy claims. Check with each insurer whether attachments are required at submission.
5. Submit via Healthcode or insurer portal: Electronic submission through Healthcode is faster and creates an auditable submission record. Bupa also accepts direct submission through its own portal for registered providers.
6. Track claim status: Follow up on outstanding claims within your normal billing cycle. Radiotherapy claims occasionally generate medical review requests, particularly when they are the first such claim from a given provider.

Anaesthetist Codes and Multiple Procedure Rules

Radiotherapy to a conjunctival lesion under CCSD Code C3950 may occasionally be performed under local anaesthesia or with anaesthetist involvement, depending on the patient and the specific technique used. When a separate anaesthetist is involved, that practitioner bills their own fee using the applicable anaesthetic codes from the CCSD schedule – these are separate from C3950 and are invoiced by the anaesthetist directly.

Freedom Health’s Chapter 4 schedule shows both a specialist fee and an anaesthetist fee column for codes in this chapter, confirming that anaesthetic fees are distinct billing items. For C3950, the Freedom Health Chapter 4 schedule (effective 01/01/2026) lists a £213.00 anaesthetist fee alongside the £200.00 specialist fee; practitioners should still confirm against the current published schedule, as fees are updated annually. Practitioners involved in leaving the NHS for private practice should familiarise themselves with this two-column fee structure early, as it differs from NHS practice where anaesthetic costs are absorbed into the institutional tariff.

Multiple procedure rules also apply when C3950 is billed alongside other ophthalmic procedures in the same session. Most insurers apply a percentage reduction to secondary and tertiary procedures on the same invoice. The exact percentage varies by insurer – AXA Health, Bupa, and Freedom Health each publish their own multiple procedure guidelines, and the private practice billing team should confirm these before submitting multi-code invoices for ophthalmic sessions.

Streamline CCSD Billing for Your Ophthalmology Practice

Pabau integrates with Healthcode to help UK private ophthalmology practices submit CCSD claims faster, track authorisations, and manage clinical documentation in one place.

Book a demo

Regulatory and Compliance Context for UK Private Ophthalmology Billing

CCSD codes are maintained by the Coding, Classification and Schedule Development group, which operates under the umbrella of the broader UK private healthcare data and governance framework. The compliance management obligations for UK private practices billing ophthalmic procedures extend beyond accurate code selection. The Private Healthcare Information Network (PHIN) collects outcomes and pricing data from private providers, and accurate CCSD coding directly affects the integrity of that data.

The Care Quality Commission (CQC) regulates independent healthcare providers in England, including those delivering radiotherapy services. While the CQC does not directly audit billing accuracy, inadequate clinical documentation – which is also the foundation of accurate billing – is assessed during inspections. Practices using specialist clinic software can automate documentation workflows so that clinical records meet both billing and regulatory standards simultaneously.

The CCSD schedule itself is a commercial document – access requires registration with CCSD directly, and the schedule requires a login to search. CCSD notes on its website that access requests are typically processed within 14 days. For practices that cannot yet access the schedule directly, individual insurer fee schedules (available from Bupa, Freedom Health, AXA, National Friendly, and others) list the codes they recognise and the fees they apply, making them a practical working reference while schedule access is pending.

Expert Picks

New to UK private healthcare billing? Bupa CCSD Codes: Complete Guide for UK Clinics covers how to find the right code, avoid common pitfalls, and submit claims electronically through Bupa’s portal.

Looking for end-to-end billing support? Pabau Claims Management Software helps private practices track CCSD claim submissions, manage authorisations, and reduce rejection rates.

Need a compliance framework for your practice records? GDPR Checklist for UK Clinics outlines the data retention and documentation obligations that underpin both clinical and billing compliance.

Conclusion

CCSD Code C3950 is a Minor complexity code covering radiotherapy to conjunctival lesion, sitting within Chapter 4 of the CCSD procedural schedule. Accurate use requires clear differentiation from adjacent codes (particularly C3920 cauterisation and C3910 excision), robust clinical documentation, pre-authorisation from the relevant insurer, and correct application of multiple procedure and anaesthetist billing rules where relevant.

For UK ophthalmology practices managing multiple insurer relationships, Pabau’s integrated claims management software supports Healthcode submission, authorisation tracking, and clinical documentation from a single platform. To see how Pabau handles CCSD billing workflows for private practices, book a demo with the team.

Frequently Asked Questions